Sanuwave Health (SNWV)
(Delayed Data from OTC)
$0.02 USD
0.00 (0.00%)
Updated May 9, 2024 03:51 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Sanuwave Health Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2 | 1 | 1 | 2 | 2 |
Receivables | 3 | 4 | 2 | 2 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 1 | 1 | 3 | 1 |
Other Current Assets | 2 | 1 | 0 | 0 | 0 |
Total Current Assets | 10 | 7 | 4 | 8 | 3 |
Net Property & Equipment | 1 | 1 | 1 | 0 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 12 | 12 | 13 | 14 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 22 | 20 | 19 | 23 | 3 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 2 | 5 |
Accounts Payable | 6 | 4 | 8 | 4 | 1 |
Current Portion Long-Term Debt | 23 | 14 | 12 | 4 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 12 | 13 | 11 | 6 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 24 | 28 | 25 | 20 | 0 |
Total Current Liabilities | 65 | 60 | 56 | 36 | 12 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 1 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 66 | 61 | 58 | 37 | 13 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 0 | 0 | 0 |
Capital Surplus | 176 | 153 | 145 | 143 | 115 |
Retained Earnings | -220 | -194 | -184 | -157 | -126 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -43 | -41 | -39 | -14 | -10 |
Total Liabilities & Shareholder's Equity | 22 | 20 | 19 | 23 | 3 |
Total Common Equity | -43 | -41 | -39 | -14 | -10 |
Shares Outstanding | 1,140.50 | 548.70 | 481.60 | 470.70 | 293.70 |
Book Value Per Share | -0.04 | -0.07 | -0.08 | -0.03 | -0.03 |
Fiscal Year End for Sanuwave Health Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 2 | 1 | 1 | 0 |
Receivables | NA | 3 | 3 | 3 | 3 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 3 | 2 | 1 | 1 |
Other Current Assets | NA | 2 | 1 | 1 | 0 |
Total Current Assets | NA | 10 | 7 | 6 | 5 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 12 | 12 | 12 | 12 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 22 | 20 | 19 | 18 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 6 | 5 | 5 | 5 |
Current Portion Long-Term Debt | NA | 23 | 35 | 18 | 15 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 12 | 12 | 14 | 15 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 24 | 33 | 43 | 36 |
Total Current Liabilities | NA | 65 | 85 | 79 | 71 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 66 | 86 | 80 | 71 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 1 |
Capital Surplus | NA | 176 | 171 | 153 | 153 |
Retained Earnings | NA | -220 | -238 | -215 | -207 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -43 | -66 | -61 | -54 |
Total Liabilities & Shareholder's Equity | NA | 22 | 20 | 19 | 18 |
Total Common Equity | 0 | -43 | -66 | -61 | -54 |
Shares Outstanding | 1,140.50 | 1,140.50 | 1,026.00 | 561.60 | 558.60 |
Book Value Per Share | 0.00 | -0.04 | -0.06 | -0.11 | -0.10 |